Simultaneous Benzodiazepine and SSRI Initiation in Young People With Anxiety Disorders.

ABSTRACT: Objective: There are potential risks and benefits of combining benzodiazepine (BZD) and selective serotonin reuptake inhibitor (SSRI) therapy at anxiety disorder treatment onset. We investigated how often adolescents and young adults with anxiety disorders simultaneously initiate BZD treatment with SSRI treatment and examined whether SSRI treatment duration varies by simultaneous BZD initiation.Methods: In a United States commercial claims database (January 2008-December 2016), we identified adolescents (10-17 years) and young adults (18-24 years) with ICD-9-CM/ICD-10-CM anxiety disorder diagnoses initiating SSRI treatment, without past-year SSRI and BZD treatment. We defined simultaneous initiation as filling a new BZD prescription on the d

SUBMITTER: Bushnell GA 

PROVIDER: S-EPMC9382882 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature